UBS AM’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

UBS AM’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-163,776	Closed	-$3.06M	–	2828
2022 Q1	$3.06M	Buy	163,776 +56,867	+53%	+$1.02M	﹤0.01%	1577
2021 Q4	$2.29M	Buy	106,909 +31,153	+41%	+$614K	﹤0.01%	1807
2021 Q3	$1.4M	Buy	75,756 +4,484	+6%	+$90.3K	﹤0.01%	1998
2021 Q2	$1.53M	Buy	+71,272	New	+$1.45M	﹤0.01%	1979

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS AM's OCDX Position: Q2 2022 in Review

UBS AM sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 163,776 shares — an estimated $3.06M sold.

UBS AM first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $3.06M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

UBS AM reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
UBS AM sold 163,776 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.06M.
UBS AM first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
UBS AM's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.06M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.